Cardium Therapeutics (NYSE: CXM)

1-Excellagen(R) is a topical gel for wound care management and 2-Generx(R) is a DNA-based angiogenic biologic intended for the treatment of coronary a....

Get a Demo and See the Full Profile

Get a demo today to see profiles of Cardium Therapeutics (NYSE: CXM) plus 5979 other startups.

Learn More About Cardium Therapeutics (NYSE: CXM)

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

CEO presentation

Competing Startups

More